About Neumora
Neumora is a neuroscience-focused biopharmaceutical company pioneering precision medicine approaches for brain diseases. The company addresses a critical global health challenge affecting over 1.5 billion people worldwide who suffer from brain disorders with limited effective treatment options. Neumora takes a fundamentally different approach to developing treatments for Central Nervous System (CNS) diseases, moving beyond the single-class drug paradigm that has dominated conditions like Major Depressive Disorder (MDD). The company's pipeline comprises programs pursuing therapeutically relevant targets implicated in CNS diseases, each targeting a novel mechanism of action with best-in-class pharmacology. Neumora's work is supported by its proprietary Precision Toolbox, which integrates a suite of translational, clinical, and computational tools to generate insights that enable precision medicine approaches. The company has assembled a team of company builders, neuroscience drug developers, and data scientists committed to revolutionizing the treatment landscape for brain diseases. By applying the precision medicine revolution that has transformed oncology to neuroscience, Neumora aims to deliver targeted, effective medicines that address the significant unmet medical needs of patients with brain disorders.
Mission & Story
Mission
Redefining Neuroscience Drug Development to Pioneer a New Era of Medicines for Brain Diseases
Clinical Focus
Medical conditions and clinical areas addressed by Neumora.
Who It Serves
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 48 →
AbleTo
AI-powered mental health and digital therapeutics platform delivering behavioral health interventions and therapy support.
Akili
Akili Interactive creates FDA-authorized digital therapeutics delivered through video game experiences to treat cognitive impairments. Their flagship products include EndeavorRx, the first FDA-approved prescription video game for children with ADHD, and EndeavorOTC for adults with ADHD.
Alma
Alma is a mental health care platform that connects clients with therapists who accept insurance across all 50 states. The company supports both clients seeking affordable therapy and mental health providers with practice management tools and insurance credentialing.
Alto Neuroscience
Alto Neuroscience develops biology-driven precision medicines for neuropsychiatric conditions. The company uses brain biology measurements to predict clinical response and identify patients most likely to benefit from their drug candidates.
BeMe Health
BeMe is a mobile mental health platform designed specifically for teens and young adults. The app provides a safe space for mood tracking, personalized content, live 1:1 coaching, and crisis support to improve emotional well-being and mental health.
Big Health
Big Health provides FDA-cleared digital therapeutics delivering cognitive behavioral therapy (CBT) for insomnia and anxiety. Their prescription products, SleepioRx and DaylightRx, serve health systems, health plans, and employers with evidence-based mental health solutions backed by 100+ peer-reviewed publications.
Blueprint Health
Blueprint provides an AI-powered assistant for mental health therapists that automates clinical documentation, generates treatment plans, and delivers clinical support. The platform works alongside existing EHRs or as a standalone AI-native EHR with integrated scheduling, telehealth, billing, and insurance management.
Boulder Care
Boulder Care provides telehealth-based addiction treatment for substance use disorder (SUD), including opioid use disorder (OUD) and alcohol use disorder (AUD). The company delivers whole-person, coordinated outpatient care through a secure mobile app, including medication-assisted treatment (MAT) with Suboxone and other medications, supported by dedicated care teams.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.